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Abstract-A

simplified two-compartment model for cell-specific chemotherapy is analysed by reformulating the governing system of differential equations as a Schrodinger equation in time. With
the choice of an exponentially decaying function representing the effects of chemotherapy on cycling
tumor cells, the potential function V(t) is a Morse-type potential, well known in the quantum mechanical literature; and the solutions are obtainable in terms of confluent hypergeometric functions
(or the related Whittaker functions). Because the chemotherapy is administered periodically, the
potential V(t) is periodic also, and use is made of existing theory (Floquet theory) as applied to
scattering by periodic potentials in the quantum theory of solids. Corresponding to the existence
“forbidden energy bands” in that context, it appears,that there are “forbidden” or inappropriate
chemotherapeutic regimens also, in the sense that for <somecombinations of period, dosage, and cell
parameters, no real solutions exist for the system of equations describing the time evolution of cancer
ceils in each compartment. A similar, but lees complex phenomenon may occur for simpler mathematical r~presantatjonsof the regimen. The purpose of this paper is to identify the existence of this
phenomenon, at least insofar as this model is concerned, and to examine the implications for clinical
activities. This new paradigm, if structually stable (in the sense of the phenomenon occurring in more
realistic models of chemotherapy) may be of considerable significance in identifying those regimens
which are appropriate for effective chemotherapy, by providing a rational basis for such decisions,
rather than by “trial and error” (see the statement by Skipper [l] at the conclusion of this paper).
Ke~ords-Chemoth~apy,

Schriidinger equation, Periodic potential, “Forbidden” regimens.

1. INTRODUCTION
In a recent paper [2], Panetta and Adam analyzed a two-compartment model of cell-specific
chemotherapy (see Figure 1). The two compartments represent cycling cells (containing the G1,
S, G2, and M phases) and resting cells, respectively. While obviously a simplistic model of the
cell cycle (or, equivalently, a simplistic model of the effects of chemotherapy), the mathematical
aspects of the model can be investigated in considerable detail, which we set out below. For
further details of the chemotherapeutic treatment, the reader is referred to [2].
The governing system of differential equations is

where x = (~1, ~2)‘; x1 and 22 represent the cycling and resting (or noncycling) tumor cell mass,
respectively. The quantity a is the rate at which cycling cells leave the cycling compartment
(including natural decay or death) minis the cycling cell growth rate, b is the rate at which
resting cells enter the cycling compartment, and p is the rate at which cycling cells enter the
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Figure 1. The tw+compsrtment
model consisting of cycling cells and resting cells.
The terms a, b, and /L are exit/entry rates defined in the introduction.

resting compartment.
All the quantities (a,&, and p> are nonnegative. The function g(t) is
continuous in any inter& (7~7,(n + 1)~)~ and describes the effects of ~emotherapy on the cycling
tumor cells. In the first period, it is defined by
g(t) = he-“‘,

0<t17,

(2)

where h is the so-called cell-kill parameter, a the drug decay or evacuation rate, 7 is the minimal
period of the function g(t), and n + 1 is the period number, n = 0, 1,2. . . .

2. SCHRijDINGER

EQUATION

FORM FOR (1)

From equation (l), the following homogeneous second-order differential equation may be derived for zl(t):
d2xl
dt2

+ G1(t)%

+ G2(+1

(3)

= 0,

in general for nr < t I (n + l)~, where
Gl(t) = a + b + g(t),

(4

Gz(t)= g’(t) + b(a - p) + bg(t).
Note also that
x2(t) = b-l

$ +(a + g(~))~l

*
>

Equation (3) may be cast into a variety of forms; in particular, Whittaker’s
which is closely related to the canonical form of the confluent hypergeometric
(see Section 3). For the moment., however, we content ourselves with a
equation into linear Schrijdinger form.
Upon substituting form (2) for g(t) into equations (3) and (4), we obtain,
dependent variable
~(4 = xl(t) exp {+(o~}

(5)
differential equation,
differential equation
reformulation of the
under the change of

(6)

the equation

C&(t) - ;G;(t)

- ;G;(t)

or after some rearrangement

@Y

z-t{K+Le

-cd + peBzat) y

=I

0,

(8)
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K = b(a - /.A)-

$3+q2,

L = 32 -a-

(n+b)),

p=+

51

(9)

= _+

We note the formal similarity between equation (8) and the linear Schrijdinger equation with
time as the independent variable, namely

2 +{;\- v(t)} y = 0,

(10)

wherein i = K is an “energy” associated with a quantum mechanical “particle” in a potential
well, V(t),in time, where
V(t) = yse-s”t

-- Le-*r,

(11)

The application of “boundary conditions” in time enable us, in principle, to identify the parameter i (which depends only on the details of the cell ~omp~tment entry and exit rates) as an
eigenvalue, but let us note first some general features of the time-potential (11). V(t)isin the
form of a Morse-type potential for a molecule (see f3] for details), and as defined here, possesses
the following properties:

6) V(0) = y2 - L.
(ii) limt+W V(t)= O-, (though, of course, the potential on (0,~) will be periodically
translated).
(iii) V(t,) = 0, where t, = o-r In (2y2,/L).
< 0.
(iv) V@*) = -(L2/4r2)
(v) V"(t*)= La2eCat*> 0 if L > 0,i.e., if
2>o+a+b.
(vi) V"(ti)= 0,where ti = t, + o-l In 2.
(vii) V(ti)= -(3L2/16y2)e
(viii) V > 0 for t < to = o-l In (r2/L).

V(t)is sketched in Figure 2.

y*-

L

Figure 2. The Morse-type potential V(t) = y2evzat - .fkTat (see equation (9))
arising from the equation (2) for g(t). This potentiaI on (0,~) is periodically repeated
in time.
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3. ANALYTIC

SOLUTIONS

FOR (8)

In (8)) we define a new independent variable
T = ?e-at
(Y
and a new dependent variable

F(T)

(12)

’

= T--P/ae0/2)TY,

(13)

where K = -p2 (K < 0 for the choice of parameters used later in Section 5) and 1 = L/2cry.
Then, (8) becomes
Tg+(z+l-T)

g-(E+;-,)F=O,

which is Kummer’s canonical form for the confluent hypergeometric

equation in which we make

the following identifications:
&+1_1

2

,=%+,
(Y

’

(15)

’

so ii = (E/2) - 1. Provided E is not an integer [4], there are two linearly independent solutions
to (14), namely
using the standard

notation

T1-“1Fl(6 - E + 1,2 - 2;; T),

and

1J’r (6, z; T)

for confluent hypergeometric

functions.

In terms of y(T(t)), the

general solution of (8) is
y(T(t)) = TP/ae-(1/2)T { AF( Zi,Z;T)+PT1-sF(ii-E+1,2-Z;
where we have now dropped the “iFi”
from (6), (12), and (16)

z,(t)

T)},

(16)

notation for simplicity. In terms of the original variables,

= ,-(1/2)(a+b)t,(h12cr)e-at~(~).

Prom (16), therefore, assimilating constants
solutions (if E is neither zero nor an integer)

(17)

into A and B, we have two linearly independent

yi(t) = e -Pte-(VaFat~

(a, 2;; se-at)

,

(18)

and
Y2(t)

=

ePte-@/We-“t

?I-E+1,2-E;~e-a’

,
>

from which (17) yields the corresponding zll’(t),

(1%

zc2)(t). If required, (5) provides the correspond-

ing expressions for s$i’(t) and z?‘(t).
An alternative form for the basis solutions (18) and (19) is in terms of Whittaker’s
hypergeometric functions (Whittaker functions). If in equation (14), we define
F = T-E/se(‘/2)TW(T),
then it can be shown after some algebra that W satisfies Whittaker’s
has the advantage of being self-adjoint
(l/4) - m2
T2

confluent

(20)
differential equation, which

(21)
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independent

solutions

of (21) are

i - 1+ m; 1 + 2m; T ,
)
( 1,

Wl,,(T)

= T(1/2)+me-(1/2)TF

wl,_,(T)

= T(1/2)-me-(1/2)TF

(22a)

and
i - 1 - m; 1 - 2m; T) .

Pb)

(
Whichever

form

of solution

we choose,

a necessary

condition

for effective

chemotherapy

is,

from (17),
zl(t

n=0,1,2

+ (n + 1)T) < s1(t + 127)

where the y(t) in (17) is b ase d on the linearly

independent

)...)

solutions

in (16) or (22).

4. THE CHEMOTHERAPEUTIC
REGIMENS
PERIODIC
POTENTIAL
If the potential

V(t)

is periodic

with minimal

period

AS A

7, i.e.,

n = 0, 1,2, . . . )

V(t + n7) = V(t),

(23)

t 2 0,

(24)

then the Schrodinger equation (10) is invariant with respect to all translations
by integer multiples
solutions of (lo), then, in
of T, t + t -t TV. If yl(t) and y=(t) are two linearly independent
particular
so are yl(t + T) and yz(t + T); indeed, these latter two solutions can be written as
linear combinations
of the former two. From within the solution space spanned by yi and ~2,
Floquet theory assures us that there are two solutions, Yl(t) and Y=(t) say, with the property
that
lqt + T) = xix(t),
i = 1,2,
(25)
where each Xi is a constant.

It naturally

Yi(t +

nT)

=

follows that

X:x(t),

i =

1,2;

n = 0, 1,2, . . . .

(26)

Let
W(Yl(t),Yz(t))
denote

the Wronskian

determinant.
W(&(t

By a well-known

theorem

= Yi(V-29)

1127)

- Yl?)Y&)

From (25), it follows that

+ r),%(t

+ 7)) =

[4], the Wronskian

x1,\2w(K,

for solutions

(t),&(t)).

of (10) is a constant,

xix2 = 1.

(23)
whence
(29)

At this point in the quantum mechanical literature
(see e.g., [3]), it is demonstrated,
using (26)
and the concept of an “infinite crystal,” that Xi and X2 are complex numbers with modulus unity
(Bloch’s theorem).
However, the independent
variable here is time, and the treatment
is finite in
An obvious constraint
is that we
duration
(see comments in [5]), so we are not thus restricted.
discard that solution y2 (say) for which X2 > 1, and retain yi for which Xi < 1. This is merely
the constraint
noted in Section 3 (equation (23)).
It is a straightforward
matter to examine (in principle,
at least) what implicit constraints
there may be on other parameters within the model. We will now drop the subscript “1” on Yi(t)
and Xi and write the former as a linear combination
of yi and ~7.. Thus,
Y(t) = &l(t)

+ By2(t),

O<t<T.

(30)
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In the next period, r I x < 27, on using (25)
Y(t) = X[Ay$

By requiring that Y(t)

and Y’(t)

- T)+ Byz(t - T)].

(31)

must be continuous at t = 7, the condition for nontrivial A

and B is the standard one, namely
Yl(T) - XYl(O)

Y2(7) - ha(O)

!I:(~)- XYi(O)

Y;(T) - XYL40) = Oy

(32)

or

X2W(0)-I- XJ(O,T) + W(T) =
where W(0)

and W(r)

respectively;

J(0, r) is defined by
4%~)

refer to the Wronskians

0,

(33)

of yr and Ys evaluated at t = 0 and t = 7,

= ~2(0)~~(~)+ ~2(~)y~tO)
- ~l(O)y~(~)
-YI(~)~~~O)=

J.

(34)

Note that W(0) = W(T) = W.
In solving (33) for A, we will retain the root X such that 0 < ReX 5 1. Those parameter values
such that ReX falls outside the interval [O,l] will be deemed as corresponding to an “ineffective”
regimen. Let us decompose the solutions of (33) in an obvious manner from
2WX = -J

rt [J2 - 4W2] (1’2) .

(35)

Both roots will be real if J2 2 4W2; both will be negative or positive if in addition, J and W have
the same or opposite signs, respectively. The roots will be complex conjugates if J2 < 4W2; in
addition, ReX will be negative or positive if J and W have the same or opposite signs accordingly.
Since j J/ZWl < 1 automatically, one root will have 0 < ReX < 1 whenever J/W < 0.
Regardless of whether X is real or complex, an optimal restriction may be obtained by considering X = eie (where 0 is a real number which may depend on the model parameters), since for
X = Reie, (R > 1), one root will be such that j X I= R and the other (of interest here) will be
such that 1X I= R-l < 1. Thus, from (35), it follows that

-J

COSB= -.
2w

(36)

Now if the model parameters were such that I& 1 > 1, it would be clear that (36) could not
be satisfied. This is the mathematical basis for the existence of “forbidden energy bands” in
solid state physics, and to this end, we examine (33) further by digressing briefly to the physical
motivating example of electrons in a periodic square lattice [3,6,7].

5. THE

“EIGENVALUE”

i

From equation (9), we have noted that
j, = K = b(a - p) - ;(a + b)2.

(37)

It is clear that i < 0, for we may rewrite this ss
i = -

bp+

;(u-&)~<0,
1

for a, b,p all positive, justifying the choice of K = -p2 in equation (13).

(38)

Certain Chemotherapeutic
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mech~ica1 problem for a potential well, such negative eigenvalues correspond

to “bound states” of the system. We may also carry over some of the terminology to advantage
in the present model. For the Morse potential V(t) described by equation (ll), the minimum
occurs at t = t, = cr-r In (2r2fL), with value V(t,) = -L2/4y2 (see Figure 3). A bound state
will be said to occur if
i E f- I V(k*) I,%

@9)

i.e., if

which places restrictions on the parameter set {a, b, p, cr}-notice
this is independent of the
dosage h-in p~ticul~r on (Y, if the remainder is prescribed, i.e., either
- (a c b)

(41)

or
- (a c b).

(42)

Note also that V(~) is positive or negative according to whether y2 - L is positive or negative,
i.e., when h is greater than or less than the quantity
4 - 2(ty i a + b),

(43)

respectively. The minimum of V(t) is actually attained if 7 2 t,.
V(O

Figure 3, The Morse potential of Figure 2 with a rectangular potentiai well superimposed upon it. The negative “eigenva;lue” parameter 5 is indicated, as are other
parameters discussed in Section 5.

In order to simplify the problem enough to illustrate the implications of the model, we replace
the Morse potenti~ (drawn in F’igure 3 for V(0) > 0) by a potential well as shown. The well
depth is V(t,) = -VO, and c = r - b measures the width of the well (b may be chosen zero if
V(0) < 0).
In terms of a periodic rectangular butier of height Vi > 0, E (positive in that problem)
= k-z, Vi -E = K$ > 0, (K2 > 0).
In terms of the multiplier X = Re i@T(R 5 l), we find from (33) or [S]
2

cos

kl b cash K;c -

(kz-K
>
-.iL--- 2
2klKs

sin kl b sinh K~c = R cos 6~~

(44)
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For the problem at hand (see Figure 3), E < 0 and VI + -VO, so we substitute E = kf =
-Kf,
K1 > 0 into (44), noting that Kz is now -Vo+Kf
< 0, so Kij = -kg < 0 for -VO < E < 0.
Under these circumstances,

a new form of (44) is obtained, namely

coshKlbcoskac+

(G)

sinhKlbsinkzc=

Rcost+

(45)

has no real solution (in terms of E or kl) for some ranges of E, viz., if kyz = rnT, m any integer,
(45) reduces to
(-l)“coshK1b

= RCOS~T,

(46)

which is, of course, impossible for nonzero real values of the parameters and R 5 1. On the other
hand, it is clear that, in particular, if kzc = $ and KI is sufficiently small, there are parameter
ranges for 8, k2, b, T, etc. for which (45) is satisfied. There will, in general, be some ranges of E,
therefore, for which (45) is satisfied. This is to be contrasted with the case of a barrier with
E < 0 (as opposed to a well with E < 0), for which (44) becomes
coshK1bcoshKzc+

(:gz)

sinhklbsinhKzc=

Rcos.87.

(47)

Since the first term on the left exceeds one for nonzero parameters, and the second term is
positive, this criterion is never satisfied for real parameters and R 5 1.
The reason for the existence of forbidden bands in the quantum-mechanical context (which
is a boundary value problem for y(z)) is that the waves, in traversing the potential V(z) are
reflected in phase by the potential and so interfere destructively with an “incoming” wave so
that it is effectively annihilated. In the present context, it appears that the “feedback” from the
chemotherapy for some ranges of dosage, period and all exit/entry rates is very counterproductive
to the succeeding segment of the regimen.
For illustrative purposes, we assign some special values to b, c, KI, and kz in equation (45).
Firstly, choose b = 7/2 = c. Now
K,2 = -fi = -E

= IEl

and

k; = -K,2 = V. - IEl.

Thus, in terms of the variable z = IEl/Vo, Klb = a(~/2)
and kg = dm(7/2),
left-hand side of equation (45) becomes, upon choosing VOTE= 4,
cosh&cosG+

((x-

1/2)/&G)sinh&sinG,

the
(48)

for 0 < IC< 1 (the limits exist as z approaches O+ and l-, respectively). If we were investigating
a potential barrier rather than a well, the appropriate domain would be z E (0,l) U(l) CXJ) (so
written because of two different expressions which occur if E > VO and E < Vo). It can be seen
from Figure 4 that f(z) > 1 (the “forbidden” region) when z exceeds about 0.57, i.e., for the
parameters chosen here, fi should be at most 57% of the “depth of the well in Figure 3.”

Figure 4. The function f(z)

defined by equation (48) for 0 < x < 1. When this ex-

ceeds unity, equation (45) cannot be satisfied for real X, R 5 1 and for the parameters
chosen.
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6. PIECEWISEUNIFORM

g(t)

If instead of the form (2), we choose a box-type function for g(t), namely

SW=

h,

0 5 t 5

0,

T<~<T,

T,

(49)

then the periodic potential in the Schrijdinger equation is correspondingIy different. Indeed, in
the sense of generalized functions, g’(t) = -hS(t - T) (see Figure 5), so that from (7)
Gz(t) - ;G:(t)

(9

= b(u -

- ;G:(f)

p) + bh -

= 6(o - cl)-+ bg + $ - &zfb+g)”

Jp+6 f

h)” -

= b(a - p) - f

(ii>

(o 4 b)2,

u/t
T

$qt- T),

OltiT,

or

T<t<T.

(50)

(51)

5

Figure 5. The box function/delta function potential (52) for the piecewise uniform g(t) defined by equation (49).

As in Section 2, we identify the terms in the Schrodinger equation (10) as
i, = b(” - /L) - ;(a + b)2 < 0,
and

$h(a - bf + $h2 + z‘h6t( - T),
VW =

o

>

OIt<T,
T<t<r.

The basic potential on (0, r) is thus a rectangular barrier of height Vo = (1/2)h(u - b) -t- (1/4)h2
(unless h < 2(b- a ) in which case VOis the well depth) and width T with a delta function “spike”
of strength h/2 at t = T (see Figure 5). Rather than analyse this model in detail at this point,
we merely decompose this problem into two subproblems, each of which represents an extreme:
(i) box function potential only, and (ii) delta function potential only.
(i) Box Function

Potential

This case is easily dealt with if Vi > 0 (i.e., a barrier) because A = E < 0 reduces the problem to
one previously discussed in Section 5. The relation (44) is neuer satisfied. In quantum mechanical
terms, all energies are forbidden; in ~emotherapeutic terms (according to this model) no regimen
works. If VO < 0 and I.,%‘[< IVol, then the situation reduces to that defined by equation (45),
namely there exists some range of E for which the regimen will not work effectively.

J. ADAM AND J. C. PANJSTTA
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(ii) Delta-function

Potential (Shifted to t = T)

The analysis for this situation is less algebraically intensive than for a piecewise-continuous
function. In the quantum theoretical literature, a periodic potential of this type is referred to as
a “Dirac comb” [3,8].
F’rom (30) and (311, we obtain, for the equation

Y(t) = AeKt f BemKt,

0<t<7,

(53)

o<t<7,

(54)

K = @l(1/2), and
Y(t) z.zx [AeK@-‘) + L(e-“+)]

,

7 < t < 27.

(55)

At t = T, we must have (i)
hm&{Y(r + E) - Y(V-- E)} = 0,

(56)

and
Iii {Y’(r + E) - Y’(T - e)} = iii

/ $(t
T-.-E

- r)Yft) dt,

Le., (ii)
hme (Y’(?- + E) - Y’(7 - E)) = iY(r).

(57)

Thus,
AeKT + Be- KT = X(A + B),

(531

and
XK(A - B) - K (AeK” - BemK7) = f (AeKT + Be-“‘).

(591

It is easily shown, directly or using (33), that
2 cash Kr + &sinhKr

x2 -

X+1 =O.
>

(

(60)

Since
q=coshKr+&sinhKr21,

(61)

we take the smallest real root
x = Tj- (q2 - 1)(1’2) 5 1,

(62)
This X is a monotone function of q, decreasing from one as q increases. Since a general requirement
for effective chemotherapy is that X is as small as possible, this corresponds to making q as large
as practical constraints on the parameters will permit. (Note that (62) is valid for all 7) 2 ‘1,
in contrast to subproblem (i) which is never satisfied for Vs > 0.) This can be accomplished
for given r by increasing K = [bh -t- (1/4)(a - b)2](1’2); in particular, increasing a and b by the
same amount would increase K and leave Vo (assumed small here to suppress the box function
contributions) unchanged. Changing a, b, and ~1may be possible in real terms through the use
of growth factors (see the discussion in Section 7). Another choice, apparently, to decrease X
is to increase the period r for given K. This permits more resting cells to move to the cycling
comp~tment,
and thus, be exposed to the ~emotherapeutic
regimen, but the submodel is not
sophisticated enough to incorporate an implicit restriction on the optimal value of r (clearly
r -+ 00 is inappropriate!).
What may we infer, in the light of these two submodels, about the full box/delta function
potential? Recalling that the first submodel implies no regimen is valid, and the second implies
that all regimens are valid (though differing in efficacy), it seems reasonable to suggest that
the full potential may exhibit regimes of validity, as does the more realistic potential based on
exponential decay discussed in Section 2.
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7. DISCUSSION
In this article, we have identified (via several variable rearrangements)
a system of ordinary
differential equations arising in a model of cell-specific chemotherapy,
with the linear Schrodinger
equation of quantum mechanics.
However, the independent
variable in this equation is time, for
obvious reasons. Furthermore,
reflecting the fact that the chemotherapeutic
regimen is periodically administered
leads to the consideration
of a periodic potential V(t). Much work has been
carried out for periodic spatial potentials V(x) (in solid state physics, for example), and some of
this material has been adapted for use in the present context.
Specifically,
cycling tumor
mechanical

the exponentially
decreasing function g(t) describing the effect of chemotherapy
on
cells in one period gives rise to a Morse-type potential, well known in the quantum

literature

(see [3] for further

references).

Solutions

to the governing

equation

can

be given in terms of confluent hypergeometric
functions (equations
(18) and (19)) or Whittaker
functions (equations
(22)). By regarding the potential V(t) as periodic, we are led in a standard
fashion to examine so-calied characteristic
multipliers
X,, i = I,2 (defined by equation
(25)).
In a spatial boundary-value
problem, these Xi are sometimes referred to as eigenvalues,
but we
retain that term for the parameter i which appears in the Schrodinger equation (10). Constraints
exist for these multipliers
Xi (see equations (33), (35), for example); there is an obvious biological
requirement
that the appropriate
Xi has modulus less than one (so that the cell population
will
decrease after each treatment).
The constraints
discussed in Section 4 are completely
general,
and utilize any appropriate
pair of linearly independent
solutions of the Schrodinger
equation.
of parameter
Thus, the sets (18), (19), and (22) are both ca.ndidates for detailed examination
space. This is not carried out in the present article because only limited information
is available
on the parameters
(see [2,9] and below.). Instead, we choose to illustrate here the fundanlental
implications
of the model by fitting a “rectangular
well” to the Morse potential V(t) (see Figure 3).
This has the decided advantage that the constraints
on the multipliers
Xi can be obtained with
relative ease. (For a very different application
of potential wells and barriers, see [lo]).
It is shown in Section 5 that the “eigenvalue” i is always negative for the model (11, and that
the governing constraint
equation for the rectangular
well is equation (45). This equation cannot
be satisfied for some ranges of i (or energy E in quantum
mechanical
terminology).
Figure 4
illustrates
a specific example of this feature. In the literature of solid state physics, such regions
of X-space are referred to as forbidden bands, and arise physically because of coherent reflections
of “waves” from the potential
that destructively
interfere with those “‘waves.” In the present
context, an appropriate
interpretation
appears to be that for certain choices of the cell exit/entry
rates a, b, a~nd p (and hence A, via (37)) the chosen dosage and period are such that some type
of negative feedback arises between a given period of administration
and the subsequent
one.
As mentioned
above, the information
on a, b, and 1-1is sparse Birkhead et al. [9] give a set of
parameter
values from breast cancer data. For this model. the set corresponds
to
a = 0.195,

/6 = 0.218,

h = 0.050,

whence from (37) i = -0.016.
If for this value of i (or other values depending on a, b, or p) and corresponding
values of Vo, T
and to in Figure 3, equation (45) cannot be satisfied, we have an inappropriate,
and therefore
ineffective regimen. Note that while i depends only on the set {a, b, p}, to = LY-’ in (r2/L) and
Vb = L2/4y2, both depend on the set {a, h, a, h). Thus, in principle, the “external”
variables
o, h, and r may be varied easily to place i in a chemotherapeutically
acceptable region such that
equation
(45) (or its analogue for the Morse potential
in terms of confluent hypergeometric
or
Whittaker
functions)
is satisfied.
However, there is another intriguing
possibility regarding the “internal” variables a, b, and p.
Growth factors increasingly
are being used to help make chemotherapeutic
drugs more effective.
Growth factors (or inhibitors)
are hormones that can stimulate
(or inhibit) the normal cellular
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proliferation processes. Further information may be found in [11,1‘2)(and also [2] for specifically
chemotherapeutic applications). They can be used to modify the entry/exit rates from one cell
compartment to another in order to optimize the cell kill rate. This corresponds to varying the
“eigenvalue” A, and again could be used to place the regimen (i.e., the full set {a, h, ~,a,b,p))
in an acceptable region of parameter space. Conversely, the use of growth factors to enhance
or optimize the cell kill rate may on occasion render the chemotherapy ineffective by modifying
some parameters in such a way that equation (45) or its more realistic analogue may no longer
be satisfied.
In Section 6, a still simpler form of g(t) is investigated.
Thii does not provide as rich a
structure as the exponential decay model, as might be expected, but it does contain a feature
that may be expected to be present in more general models of the type discussed in this paper,
especially if a discontinuity in g(t) occurs for t E (0,~); i.e., in the fundamental domain. The
two submodels considered represent extremes in the sense that any more realistic model (such
as that considered in the main body of this paper, based on equation (2)) can be expected to
exhibit a wide range of behavior, in that some regimens (or parameter sets) are effective (i.e.,
“allowed” by the system) and others are not. This is indeed the case for the exponential decay
model discussed here. Having established the possibility of such a paradigm, or way of viewing
the periodic administration of drugs to destroy tumor cells, it will be of great interest to examine
more detailed models and their domains of parameter validity as more experimental and clinical
information becomes available. This may eventually provide a rational basis for the “trial and
error” method so clearly described by Skipper [l]:
Over 20 years of experimental and clinical experience has demonstrated that intuitive
or trial-and-error manipulations of doses, schedules, and combination of drugs-without
guidance as to the effects of each manipulation-are
apt to provide little or no improvement in combination chemotherapy designs.
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